Several top tech CEOs, once critical of Donald Trump, are now aligning with his administration as he prepares for his second term. This shift is driven by impending regulations on AI, social media safeguards,

OpenAI CEO Altman, 39, and Amazon founder Bezos, 60, have shelled out millions in recent years to longevity labs Retro Biosciences and Altos Labs, respectively. PayPal cofounder Thiel, 57, forked over $1 million to the Methuselah Foundation, a biomedical charity that aims to make 90 the new 50 by 2030.

NEW YORK, Jan 8: Jeff Bezos, Sam Altman, and Peter Thiel have already conquered the tech world, but now they're investing millions in a new battle: the quest for eternal youth. These tech billionaires are pouring vast sums of their fortunes into the race to extend life, fueling the growth of a $25 billion market for life-extending therapies.

World’s-richest-man Elon Musk, Meta CEO Mark Zuckerberg, and Amazon chief Jeff Bezos are slated to attend the forty-seventh president’s inauguration next week, according to NBC News. The tech trio will be seated alongside elected officials and Trump’s Cabinet selections.

Tech billionaires like Elon Musk, Jeff Bezos, and Mark Zuckerberg follow disciplined morning routines to boost productivity and creativity. Their habi

Sam Altman says his researchers still push back in meetings — a positive for him. Altman previously wrote that he was against bureaucracy and supported fostering open communication. Workplace ...

Here's what you need to know this week about artificial intelligence in the Bay Area: Musk pushes for OpenAI auction, Altman sued by sister, Anthropic partially settles lawsuit with music publishers,

Amazon founder Jeff Bezos previously planned to donate $1 ... Facebook's Mark Zuckerberg, OpenAI CEO Sam Altman and others kneeling before Trump. Amazon Prime Video announced Sunday that it ...

Nvidia CEO Jensen Huang is open to meeting President-elect Donald Trump at his resort but hasn't received an invitation yet. Other notable tech leader

In fact, he cozied up to Trump by trolling Democrats who sent a letter over concerns that Altman was...cozying up to Trump. Democratic Sens. Elizabeth Warren and Michael Bennet se

A Midtown-based therapeutics company hopes to tap the growing market of anti-aging drugs with a suite of pharmaceutical research, and investors are taking notice. Cambrian Bio recently raised $23 million to advance its portfolio of drug discovery platforms focused on the biological processes that break down with age.